GPC3-CAR T cells (IL-15/IL-21 armored)

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPC3-CAR T cells (IL-15/IL-21 armored), covering 2025-11-03 to 2025-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells [Phase 1]